Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Endosc. Sep 16, 2024; 16(9): 519-525
Published online Sep 16, 2024. doi: 10.4253/wjge.v16.i9.519
Table 1 Baseline characteristics and comparison of post-endoscopic retrograde cholangiopancreatography pancreatitis incidence between needle-knife precut papillotomy cases and non-needle-knife precut papillotomy cases
Characteristic
NKPP, n = 294
Non-NKPP, n = 1262
P value
Age75.5 ± 13.073.6 ± 13.40.016
Sex, male159 (53.7)690 (54.6)0.80
Diagnosis< 0.01
Benign205 (69.3)980 (77.6)
Malignancy91 (30.7)283 (22.4)
Diverticula77 (26.0)380 (30.1)0.18
First endoscopist0.050
Trainee, n = 903156 (53.0)747 (59.2)
Success rate of cannulation283 (96.3)1250 (99.0)< 0.01
Cannulation time in min20.3 ± 12.65.1 ± 7.2< 0.01
Total procedure time in min40.4 ± 16.029.7 ± 17.9< 0.01
PEP21 (7.1)68 (5.4)0.27
Table 2 Baseline characteristics and result of the incident rate of post-endoscopic retrograde cholangiopancreatography pancreatitis between early needle-knife precut papillotomy group and delayed needle-knife precut papillotomy group
Characteristic
EP group, n = 142
DP group, n = 152
P value
Age74.8 ± 13.676.3 ± 12.40.39
Sex, male81 (57)77 (50.7)0.29
Diagnosis
Benign101 (71.1)103 (67.8)0.61
Malignancy41 (28.9)49 (32.2)
Diverticula30 (21.1)47 (37.6)0.064
First endoscopist< 0.01
Trainee, n = 15443 (30.3)111 (73.0)
Trainer, n = 14199 (69.7)41 (27.0)
NKPP start time in min5.7 ± 3.117.1 ± 5.6< 0.01
Success rate of cannulation140 (98.6)143 (94.1)0.027
Cannulation time in min13.2 ± 8.627.3 ± 12.0< 0.01
Total procedure time in min35.0 ± 15.745.8 ± 14.4< 0.01
PEP5 (3.5)16 (10.5)0.023
Table 3 Analysis of efficacy of endoscopic pancreatic stenting for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention
Complication
EP group, n = 142
DP group, n = 152
P value
Without EPS, n = 79
With EPS, n = 63
Without EPS, n = 75
With EPS, n = 77
PEP3 (3.8)2 (3.2)13 (17.3)3 (3.9)< 0.01a